Stockscreener 앱 받기
40.26
3.34%
1.30
시간 외 거래:
40.26
Immunovant Inc 주식(IMVT)의 최신 뉴스
Immunovant chief legal officer Van Tuyl sells $47,702 in stock By Investing.com - Investing.com India
Immunovant CTO Jay Stout sells $137,924 in IMVT stock - Investing.com
Immunovant CTO Jay Stout sells $137,924 in IMVT stock By Investing.com - Investing.com South Africa
Form 4 Immunovant Inc For: 10 July By Investing.com - Investing.com Nigeria
Immunovant chief legal officer Van Tuyl sells $47,702 in stock - Investing.com
Immunovant COO Melanie Gloria sells $80,531 in shares By Investing.com - Investing.com South Africa
Immunovant COO Melanie Gloria sells $80,531 in shares - Investing.com
Immunovant (IMVT) COO offloads 2,036 shares to cover RSU tax withholding - Stock Titan
Immunovant (IMVT) legal chief sells 1,206 shares in tax “sell to cover” - Stock Titan
Immunovant (IMVT) CTO offloads 3,487 shares in mandated RSU tax-withholding sales - Stock Titan
LifeSci Capital Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $53 - Moomoo
Emerging Therapies Transforming the Myasthenia Gravis Market by DelveInsight | Sanofi, Cartesian Therapeutics, Takeda, UCB Biopharma, Roche, Janssen R&D, Immunovant Sciences GmbH, Argenx-Halozyme - Barchart.com
Immunovant Inc explores long term growth paths as autoimmune pipeline advances - ad-hoc-news.de
Understanding Momentum Shifts in (IMVT) - Stock Traders Daily
Immunovant stock hits 52-week high at 39.28 USD By Investing.com - Investing.com South Africa
Immunovant stock hits 52-week high at 39.28 USD - Investing.com
Immunovant Inc outlines its autoimmune drug pipeline as investors watch clinical milestones - ad-hoc-news.de
Form 4 Immunovant Inc For: 6 July By Investing.com - Investing.com Nigeria
Immunovant CEO Eric Venker sells $118,980 of IMVT stock - Investing.com UK
Immunovant CEO Eric Venker sells $118,980 of IMVT stock By Investing.com - Investing.com Nigeria
Immunovant (IMVT) CEO settles CVARs with small tax-related share sale - Stock Titan
All You Need to Know About Immunovant (IMVT) Rating Upgrade to Buy - MSN
IMVTImmunovant Inc Earnings - Finviz
Chief Technology Officer Of Immunovant Sold 53% Of Their Shares - Sahm
Immunovant (IMVT) up 3.6% since last earnings report: Can it continue? - MSN
IMVT Maintained by Citigroup -- Price Target Raised to $61.00 - GuruFocus
Immunovant Insider Sold Shares Worth $1,532,309, According to a Recent SEC Filing - Moomoo
Citi Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $61 - Moomoo
Immunovant COO Melanie Gloria sells $678k in company stock By Investing.com - Investing.com India
Immunovant CFO Tiago Girao sells $384,600 in company stock By Investing.com - Investing.com Nigeria
Form 144 IMMUNOVANT For: 26 June By Investing.com - Investing.com South Africa
Immunovant chief legal officer sells $682,886 in stock By Investing.com - Investing.com Nigeria
Insider Sell: Melanie Gloria Sells 17,714 Shares of Immunovant I - GuruFocus
Form 4 Immunovant Inc For: 26 June By Investing.com - Investing.com Nigeria
Avoiding Lag: Real-Time Signals in (IMVT) Movement - Stock Traders Daily
Immunovant CTO Jay Stout sells $1.53m in company stock By Investing.com - Investing.com Australia
Immunovant chief legal officer sells $682,886 in stock - Investing.com
Immunovant (IMVT) CFO exercises options, sells 10,000 shares at ~$38 average - Stock Titan
0.80%
2.11%
자본화:
|
볼륨(24시간):